360 related articles for article (PubMed ID: 29577894)
21. Quinolinic acid-induced increases in calbindin D28k immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington's disease.
Huang Q; Zhou D; Sapp E; Aizawa H; Ge P; Bird ED; Vonsattel JP; DiFiglia M
Neuroscience; 1995 Mar; 65(2):397-407. PubMed ID: 7777157
[TBL] [Abstract][Full Text] [Related]
22. L-theanine prevent quinolinic acid induced motor deficit and striatal neurotoxicity: Reduction in oxido-nitrosative stress and restoration of striatal neurotransmitters level.
Jamwal S; Singh S; Gill JS; Kumar P
Eur J Pharmacol; 2017 Sep; 811():171-179. PubMed ID: 28624333
[TBL] [Abstract][Full Text] [Related]
23. Ebselen blocks the quinolinic acid-induced production of thiobarbituric acid reactive species but does not prevent the behavioral alterations produced by intra-striatal quinolinic acid administration in the rat.
Rossato JI; Zeni G; Mello CF; Rubin MA; Rocha JB
Neurosci Lett; 2002 Feb; 318(3):137-40. PubMed ID: 11803118
[TBL] [Abstract][Full Text] [Related]
24. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease.
Hughes PE; Alexi T; Williams CE; Clark RG; Gluckman PD
Neuroscience; 1999; 92(1):197-209. PubMed ID: 10392842
[TBL] [Abstract][Full Text] [Related]
25. S-Allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats.
Pérez-Severiano F; Rodríguez-Pérez M; Pedraza-Chaverrí J; Maldonado PD; Medina-Campos ON; Ortíz-Plata A; Sánchez-García A; Villeda-Hernández J; Galván-Arzate S; Aguilera P; Santamaría A
Neurochem Int; 2004 Dec; 45(8):1175-83. PubMed ID: 15380627
[TBL] [Abstract][Full Text] [Related]
26. Neuroprotective effect of interleukin-6 and IL6/IL6R chimera in the quinolinic acid rat model of Huntington's syndrome.
Bensadoun JC; de Almeida LP; Dréano M; Aebischer P; Déglon N
Eur J Neurosci; 2001 Dec; 14(11):1753-61. PubMed ID: 11860469
[TBL] [Abstract][Full Text] [Related]
27. Intranigral or intrastriatal injections of GDNF: effects on monoamine levels and behavior in rats.
Martin D; Miller G; Cullen T; Fischer N; Dix D; Russell D
Eur J Pharmacol; 1996 Dec; 317(2-3):247-56. PubMed ID: 8997607
[TBL] [Abstract][Full Text] [Related]
28. Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease.
Wei H; Qin ZH; Senatorov VV; Wei W; Wang Y; Qian Y; Chuang DM
Neuroscience; 2001; 106(3):603-12. PubMed ID: 11591460
[TBL] [Abstract][Full Text] [Related]
29. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease.
Kumar P; Kumar A
J Med Food; 2009 Jun; 12(3):591-600. PubMed ID: 19627208
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial cofactors in experimental Huntington's disease: behavioral, biochemical and histological evaluation.
Mehrotra A; Sandhir R
Behav Brain Res; 2014 Mar; 261():345-55. PubMed ID: 24393741
[TBL] [Abstract][Full Text] [Related]
31. NAD(P)H oxidase contributes to neurotoxicity in an excitotoxic/prooxidant model of Huntington's disease in rats: protective role of apocynin.
Maldonado PD; Molina-Jijón E; Villeda-Hernández J; Galván-Arzate S; Santamaría A; Pedraza-Chaverrí J
J Neurosci Res; 2010 Feb; 88(3):620-9. PubMed ID: 19795371
[TBL] [Abstract][Full Text] [Related]
32. L-theanine, a Component of Green Tea Prevents 3-Nitropropionic Acid (3-NP)-Induced Striatal Toxicity by Modulating Nitric Oxide Pathway.
Jamwal S; Kumar P
Mol Neurobiol; 2017 Apr; 54(3):2327-2337. PubMed ID: 26957301
[TBL] [Abstract][Full Text] [Related]
33. CSC, an adenosine A(2A) receptor antagonist and MAO B inhibitor, reverses behavior, monoamine neurotransmission, and amino acid alterations in the 6-OHDA-lesioned rats.
Aguiar LM; Macêdo DS; Vasconcelos SM; Oliveira AA; de Sousa FC; Viana GS
Brain Res; 2008 Jan; 1191():192-9. PubMed ID: 18164694
[TBL] [Abstract][Full Text] [Related]
34. The quinolinic acid model of Huntington's disease: locomotor abnormalities.
Sanberg PR; Calderon SF; Giordano M; Tew JM; Norman AB
Exp Neurol; 1989 Jul; 105(1):45-53. PubMed ID: 2526022
[TBL] [Abstract][Full Text] [Related]
35. Spermidine ameliorates 3-nitropropionic acid (3-NP)-induced striatal toxicity: Possible role of oxidative stress, neuroinflammation, and neurotransmitters.
Jamwal S; Kumar P
Physiol Behav; 2016 Mar; 155():180-7. PubMed ID: 26703234
[TBL] [Abstract][Full Text] [Related]
36. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats.
Tariq M; Khan HA; Elfaki I; Al Deeb S; Al Moutaery K
Brain Res Bull; 2005 Sep; 67(1-2):161-8. PubMed ID: 16140176
[TBL] [Abstract][Full Text] [Related]
37. Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats.
Danduga RCSR; Dondapati SR; Kola PK; Grace L; Tadigiri RVB; Kanakaraju VK
Biomed Pharmacother; 2018 Sep; 105():1254-1268. PubMed ID: 30021362
[TBL] [Abstract][Full Text] [Related]
38. Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor-Upsilon (PPARUpsilon) in Huntington's disease.
Kalonia H; Kumar P; Kumar A
Pharmacol Biochem Behav; 2010 Aug; 96(2):115-24. PubMed ID: 20450929
[TBL] [Abstract][Full Text] [Related]
39. Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies.
Santamaría A; Salvatierra-Sánchez R; Vázquez-Román B; Santiago-López D; Villeda-Hernández J; Galván-Arzate S; Jiménez-Capdeville ME; Ali SF
J Neurochem; 2003 Jul; 86(2):479-88. PubMed ID: 12871589
[TBL] [Abstract][Full Text] [Related]
40. Attenuation of proinflammatory cytokines and apoptotic process by verapamil and diltiazem against quinolinic acid induced Huntington like alterations in rats.
Kalonia H; Kumar P; Kumar A
Brain Res; 2011 Feb; 1372():115-26. PubMed ID: 21112316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
